EH Bel

803 total citations
16 papers, 458 citations indexed

About

EH Bel is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, EH Bel has authored 16 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 6 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in EH Bel's work include Asthma and respiratory diseases (12 papers), Respiratory and Cough-Related Research (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). EH Bel is often cited by papers focused on Asthma and respiratory diseases (12 papers), Respiratory and Cough-Related Research (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). EH Bel collaborates with scholars based in Netherlands, United Kingdom and United States. EH Bel's co-authors include PJ Sterk, Joop H. Dijkman, Peter Sterk, Aeilko H. Zwinderman, Mieke Timmers, Gijsbert P. van Nierop, A. H. Zwinderman, Ewa Niżankowska‐Mogilnicka, Peter Howarth and Mark Gjomarkaj and has published in prestigious journals such as European Respiratory Journal, Thorax and Allergy.

In The Last Decade

EH Bel

14 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
EH Bel Netherlands 7 413 353 70 32 28 16 458
Joceline Otis Canada 6 256 0.6× 231 0.7× 38 0.5× 27 0.8× 12 0.4× 8 376
G. Gambaro Italy 6 342 0.8× 208 0.6× 53 0.8× 43 1.3× 16 0.6× 7 400
Wolfgang Seibold Germany 6 478 1.2× 447 1.3× 50 0.7× 25 0.8× 15 0.5× 15 528
Olaf Schmidt Germany 10 439 1.1× 457 1.3× 37 0.5× 13 0.4× 19 0.7× 37 505
Berardino Mastropasqua Italy 9 476 1.2× 327 0.9× 333 4.8× 39 1.2× 23 0.8× 25 535
Nicoletta M. Azzolin Italy 8 581 1.4× 512 1.5× 94 1.3× 8 0.3× 26 0.9× 10 671
Andrea Pelucchi Italy 9 429 1.0× 320 0.9× 302 4.3× 36 1.1× 21 0.8× 12 497
Theo A. Bantje Netherlands 8 403 1.0× 391 1.1× 31 0.4× 6 0.2× 7 0.3× 9 435
H. Geoffrey Watson United States 6 281 0.7× 129 0.4× 33 0.5× 89 2.8× 53 1.9× 6 402
Arlene Donnelly United States 7 288 0.7× 181 0.5× 188 2.7× 19 0.6× 12 0.4× 9 354

Countries citing papers authored by EH Bel

Since Specialization
Citations

This map shows the geographic impact of EH Bel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EH Bel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EH Bel more than expected).

Fields of papers citing papers by EH Bel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by EH Bel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EH Bel. The network helps show where EH Bel may publish in the future.

Co-authorship network of co-authors of EH Bel

This figure shows the co-authorship network connecting the top 25 collaborators of EH Bel. A scholar is included among the top collaborators of EH Bel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with EH Bel. EH Bel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Khurana, Sandhya, Eric Bradford, M Gilson, et al.. (2020). Long-term safety and durability of mepolizumab in life-threatening/seriously debilitating severe eosinophilic asthma (SEA): COSMEX. Pneumologie. 1 indexed citations
2.
Bel, EH, Oliver Kornmann, Marc Humbert, et al.. (2020). P211 CLINICIAN/PATIENT PERCEPTION: ASTHMA SEVERITY DECREASES AND RESPONSE INCREASES WITH CONTINUING VERSUS STOPPING LONG-TERM MEPOLIZUMAB (COMET). Annals of Allergy Asthma & Immunology. 125(5). S30–S30. 1 indexed citations
3.
Moore, Wendy C., Oliver Kornmann, Marc Humbert, et al.. (2020). Outcomes Following Continuation or Stopping Long-Term Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma: The Randomized Comet Trial. A4211–A4211. 3 indexed citations
4.
Vijverberg, Susanne J. H., Maria Prins, Marieke B. Snijder, et al.. (2019). Prevalence of and factors associated with adult-onset asthma in different ethnic groups: The HELIUS study. Respiratory Medicine. 150. 113–119. 14 indexed citations
5.
6.
Bel, EH, et al.. (2014). Late-breaking abstract: Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: The SIRIUS study. European Respiratory Journal. 44(Suppl 58). 2907–2907. 8 indexed citations
7.
Bel, EH, Sally E. Wenzel, Philip J. Thompson, et al.. (2014). Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: The SIRIUS study. 44. 2 indexed citations
8.
Kupczyk, Maciej, Barbro Dahlén, Peter Sterk, et al.. (2014). Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma. Allergy. 69(9). 1198–1204. 75 indexed citations
9.
Groot, Jan Cees de, et al.. (2014). The effect of vitamin D on airway inflammation in non-atopic asthma. 189. 1 indexed citations
10.
Hashimoto, Simone, Anneke Ten Brinke, Jacob K. Sont, et al.. (2009). Patterns of Daily Exhaled Nitric Oxide (F E NO) in Severe, Steroid-Dependent Asthma.. A5712–A5712.
11.
12.
Pavord, Ian, Peter Sterk, F.E. Hargreave, et al.. (2002). Clinical applications of assessment of airway inflammation using induced sputum. European Respiratory Journal. 20(37 suppl). 40s–43s. 56 indexed citations
13.
Nierop, Gijsbert P. van, et al.. (1992). Auranofin in the treatment of steroid dependent asthma: a double blind study.. Thorax. 47(5). 349–354. 49 indexed citations
14.
Bel, EH, Aeilko H. Zwinderman, Mieke Timmers, Joop H. Dijkman, & Peter Sterk. (1991). The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.. Thorax. 46(1). 9–14. 64 indexed citations
15.
Sterk, PJ & EH Bel. (1989). Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing. European Respiratory Journal. 2(3). 267–274. 177 indexed citations
16.
Sterk, PJ, et al.. (1988). The combined effects of histamine and methacholine on the maximal degree of airway narrowing in normal humans in vivo. European Respiratory Journal. 1(1). 34–40. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joceline Otis Breakdown of academic impact, for papers by G. Gambaro Breakdown of academic impact, for papers by Wolfgang Seibold Breakdown of academic impact, for papers by Olaf Schmidt Breakdown of academic impact, for papers by Berardino Mastropasqua Breakdown of academic impact, for papers by Nicoletta M. Azzolin Breakdown of academic impact, for papers by Andrea Pelucchi Breakdown of academic impact, for papers by Theo A. Bantje Breakdown of academic impact, for papers by H. Geoffrey Watson Breakdown of academic impact, for papers by Arlene Donnelly
Rankless by CCL
2026